Bio & Insurance Information

Dr. Preet Chaudhary graduated from the Maulana Azad Medical College and completed his residency program at the McGaw Medical Center of Northwestern University. Then, he did a fellowship at the University of Washington. He is specialized in Medical Oncology and board certified in Oncology. Dr. Chaudhary has been in practice for more than 20 years and is affiliated with the Keck Hospital of USC, Los Angeles County-USC Medical Center, and the USC Norris Comprehensive Cancer Center. During his career, he has also contributed to various clinical research publications.



Education & Training

Maulana Azad Medical College

Medical School

McGaw Medical Center of Northwestern University

Residency

University of Washington

Fellowship

Board Certifications

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Medical License

CA State Medical License 2010 - 2017

TX State Medical License 1999 - 2018

Hospitals & Clinics

Keck Hospital of USC - Medical Center

Languages: English/Spanish

(323) 442-8500

1500 San Pablo St

Los Angeles, California 90033

Read More

University of California - Los Angeles Medical Center

Languages: English/Spanish

(310) 794-7953

10833 Le Conte Ave

Los Angeles, California 90095

Read More

USC Norris Comprehensive Cancer Center

Languages: English/Spanish

(323) 865-3000

1441 Eastlake Avenue

Los Angeles, California 90033

Read More

Publications

Dr. Preet Chaudhary has contributed to 3 publications.

DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections.

Liu, C. C.,Tseng, Y. T.,Li, W.,Wu, C. Y.,Mayzus, I.,Rzhetsky, A.,Sun, F.,Waterman, M.,Chen, J. J.,Chaudhary, P. M.,Loscalzo, J.,Crandall, E.,Zhou, X. J.; Nucleic Acids Res.. 2014 Jun 05.

See more >>

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.

Tolani, B.,Gopalakrishnan, R.,Punj, V.,Matta, H.,Chaudhary, P. M.; Oncogene. 2013 Jun 25.

See more >>

NEMO is essential for KSHV-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death and its N-terminal 251 residues are suffi...

Tolani, B.,Matta, H.,Gopalakrishnan, R.,Punj, V.,Chaudhary, P. M.; J. Virol.. 2014 Mar 29.

See more >>